151 related articles for article (PubMed ID: 36451601)
1. Association between polypharmacy and depression relapse in individuals with comorbid depression and type 2 diabetes: a UK electronic health record study.
Jeffery A; Bhanu C; Walters K; Wong ICK; Osborn D; Hayes JF
Br J Psychiatry; 2023 Mar; 222(3):112-118. PubMed ID: 36451601
[TBL] [Abstract][Full Text] [Related]
2. Polypharmacy and antidepressant acceptability in comorbid depression and type 2 diabetes: a cohort study using UK primary care data.
Jeffery A; Bhanu C; Walters K; Wong IC; Osborn D; Hayes JF
Br J Gen Pract; 2023 May; 73(730):e392-e398. PubMed ID: 37105749
[TBL] [Abstract][Full Text] [Related]
3. Antidepressant medication to prevent depression relapse in primary care: the ANTLER RCT.
Duffy L; Clarke CS; Lewis G; Marston L; Freemantle N; Gilbody S; Hunter R; Kendrick T; Kessler D; King M; Lanham P; Mangin D; Moore M; Nazareth I; Wiles N; Bacon F; Bird M; Brabyn S; Burns A; Donkor Y; Hunt A; Pervin J; Lewis G
Health Technol Assess; 2021 Nov; 25(69):1-62. PubMed ID: 34842135
[TBL] [Abstract][Full Text] [Related]
4. Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults.
Van Leeuwen E; van Driel ML; Horowitz MA; Kendrick T; Donald M; De Sutter AI; Robertson L; Christiaens T
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013495. PubMed ID: 33886130
[TBL] [Abstract][Full Text] [Related]
5. The epidemiology of antidepressant use in South Korea: Does short-term antidepressant use affect the relapse and recurrence of depressive episodes?
Kim MJ; Kim N; Shin D; Rhee SJ; Park CHK; Kim H; Cho SJ; Lee JW; Kim EY; Yang B; Ahn YM
PLoS One; 2019; 14(9):e0222791. PubMed ID: 31553786
[TBL] [Abstract][Full Text] [Related]
6. The association between antidepressant treatment and rates of insulin initiation in comorbid depression and type 2 diabetes: A UK electronic health record nested case-control study.
Jeffery A; Walters K; Wong ICK; Osborn D; Hayes JF
Diabetes Res Clin Pract; 2024 Mar; 209():111083. PubMed ID: 38159576
[TBL] [Abstract][Full Text] [Related]
7. Discontinuation of antidepressants: Is there a minimum time on treatment that will reduce relapse risk?
Liu X; Momen NC; Molenaar N; Rommel AS; Bergink V; Munk-Olsen T
J Affect Disord; 2021 Jul; 290():254-260. PubMed ID: 34010750
[TBL] [Abstract][Full Text] [Related]
8. Monitoring patients on chronic treatment with antidepressants between 2003 and 2011: analysis of factors associated with compliance.
Serna MC; Real J; Cruz I; Galván L; Martin E
BMC Public Health; 2015 Nov; 15():1184. PubMed ID: 26611468
[TBL] [Abstract][Full Text] [Related]
9. Association Between the Use of Antidepressants and the Risk of Type 2 Diabetes: A Large, Population-Based Cohort Study in Japan.
Miidera H; Enomoto M; Kitamura S; Tachimori H; Mishima K
Diabetes Care; 2020 Apr; 43(4):885-893. PubMed ID: 32051242
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of preventive cognitive therapy while tapering antidepressants versus maintenance antidepressant treatment versus their combination in prevention of depressive relapse or recurrence (DRD study): a three-group, multicentre, randomised controlled trial.
Bockting CLH; Klein NS; Elgersma HJ; van Rijsbergen GD; Slofstra C; Ormel J; Buskens E; Dekker J; de Jong PJ; Nolen WA; Schene AH; Hollon SD; Burger H
Lancet Psychiatry; 2018 May; 5(5):401-410. PubMed ID: 29625762
[TBL] [Abstract][Full Text] [Related]
11. The effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse/recurrence: results of a randomised controlled trial (the PREVENT study).
Kuyken W; Hayes R; Barrett B; Byng R; Dalgleish T; Kessler D; Lewis G; Watkins E; Morant N; Taylor RS; Byford S
Health Technol Assess; 2015 Sep; 19(73):1-124. PubMed ID: 26379122
[TBL] [Abstract][Full Text] [Related]
12. General practice-recorded depression and antidepressant use in young people with newly diagnosed Type 1 diabetes: a cohort study using the Clinical Practice Research Datalink.
Morgan E; Patterson CC; Cardwell CR
Diabet Med; 2014 Feb; 31(2):241-5. PubMed ID: 24111949
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse or recurrence (PREVENT): a randomised controlled trial.
Kuyken W; Hayes R; Barrett B; Byng R; Dalgleish T; Kessler D; Lewis G; Watkins E; Brejcha C; Cardy J; Causley A; Cowderoy S; Evans A; Gradinger F; Kaur S; Lanham P; Morant N; Richards J; Shah P; Sutton H; Vicary R; Weaver A; Wilks J; Williams M; Taylor RS; Byford S
Lancet; 2015 Jul; 386(9988):63-73. PubMed ID: 25907157
[TBL] [Abstract][Full Text] [Related]
14. Clinical factors associated with relapse in depression in a sample of UK primary care patients who have been on long-term antidepressant treatment.
Duffy L; Lewis G; Marston L; Kendrick T; Kessler D; Moore M; Wiles N; Lewis G
Psychol Med; 2024 Apr; 54(5):951-961. PubMed ID: 37753652
[TBL] [Abstract][Full Text] [Related]
15. Antidepressants for people with epilepsy and depression.
Maguire MJ; Weston J; Singh J; Marson AG
Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD010682. PubMed ID: 25464360
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant therapy with antidepressants for the management of inflammatory bowel disease.
Mikocka-Walus A; Prady SL; Pollok J; Esterman AJ; Gordon AL; Knowles S; Andrews JM
Cochrane Database Syst Rev; 2019 Apr; 4(4):CD012680. PubMed ID: 30977111
[TBL] [Abstract][Full Text] [Related]
17. Antidepressant medication use in Inflammatory Bowel Disease: a nationally representative population-based study.
Jayasooriya N; Blackwell J; Saxena S; Bottle A; Petersen I; Creese H; Hotopf M; Pollok RCG;
Aliment Pharmacol Ther; 2022 May; 55(10):1330-1341. PubMed ID: 35244961
[TBL] [Abstract][Full Text] [Related]
18. Impact of Antidepressant Use on Healthcare Utilization among Individuals with Type 2 Diabetes and Depression Symptoms in the United States: Sociodemographic, Clinical, and Behavioral Factors Matter.
Binsaleh AY; Perez A; Popovici I; Rabionet SE
Int J Environ Res Public Health; 2018 Sep; 15(9):. PubMed ID: 30200470
[TBL] [Abstract][Full Text] [Related]
19. Antidepressants for people with epilepsy and depression.
Maguire MJ; Marson AG; Nevitt SJ
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD010682. PubMed ID: 33860531
[TBL] [Abstract][Full Text] [Related]
20. Initiation of antidepressant medication in people with type 2 diabetes living in the United Kingdom-A retrospective cohort study.
Pal K; Sharma M; Mukadam NM; Petersen I
Pharmacoepidemiol Drug Saf; 2022 Aug; 31(8):892-900. PubMed ID: 35638365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
